Iantrek

Developing micro-interventional technologies for treating glaucoma.

Medical DevicesOphthalmology iantrekmed.com ↗

Company facts

Founded
2019
Employees
75
Headquarters
United States
Type
Private
Funding
Series C · $42M · 2025